Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jette Junge

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Cancer Causes & Control : CCC|June 3, 2015
Trends in the incidence of cervical cancer and severe precancerous lesions in Denmark, 1997-2012Birgitte Baldur-Felskov, Christian Munk, Thor Schütt Svane Nielsen, et al.
Acta Obstetricia Et Gynecologica Scandinavica|May 8, 2013
HPV-genotypes in high-grade intraepithelial cervical lesions in Danish womenBenny Kirschner, Doris Schledermann, Katsiaryna Holl, et al.
Acta Obstetricia Et Gynecologica Scandinavica|June 15, 2013
HPV genotypes in invasive cervical cancer in Danish womenBenny Kirschner, Jette Junge, Katsiaryna Holl, et al.
Gynecologic Oncology|March 11, 2014
Prevalence of Human Papillomavirus in endometrial cancer: a systematic review and meta-analysisTina Bech Olesen, Malene Frøsig Svahn, Mette Tuxen Faber, et al.
Gynecologic Oncology|January 22, 2017
Parity, infertility, oral contraceptives, and hormone replacement therapy and the risk of ovarian serous borderline tumors: A nationwide case-control studyEmma L Kaderly Rasmussen, Charlotte Gerd Hannibal, Christian Dehlendorff, et al.
The American Journal of Surgical Pathology|September 5, 2014
BRAF mutation is associated with a specific cell type with features suggestive of senescence in ovarian serous borderline (atypical proliferative) tumorsFelix Zeppernick, Laura Ardighieri, Charlotte G Hannibal, et al.
The Journal of Pathology|December 6, 2013
Mutational analysis of BRAF and KRAS in ovarian serous borderline (atypical proliferative) tumours and associated peritoneal implantsLaura Ardighieri, Felix Zeppernick, Charlotte G Hannibal, et al.
Gynecologic Oncology|June 14, 2014
A nationwide study of serous "borderline" ovarian tumors in Denmark 1978-2002: centralized pathology review and overall survival compared with the general populationCharlotte Gerd Hannibal, Russell Vang, Jette Junge, et al.
BMC Infectious Diseases|June 3, 2014
Adherence to the cervical cancer screening program in women living with HIV in Denmark: comparison with the general populationKristina Thorsteinsson, Steen Ladelund, Søren Jensen-Fangel, et al.
Sexually Transmitted Diseases|February 17, 2012
Human papillomavirus prevalence and type distribution in 3603 HIV-positive and HIV-negative women in the general population of Tanzania: the PROTECT studyMyassa Dartell, Vibeke Rasch, Crispin Kahesa, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Cancer Causes & Control : CCC|June 3, 2015
Trends in the incidence of cervical cancer and severe precancerous lesions in Denmark, 1997-2012Birgitte Baldur-Felskov, Christian Munk, Thor Schütt Svane Nielsen, et al.
Acta Obstetricia Et Gynecologica Scandinavica|May 8, 2013
HPV-genotypes in high-grade intraepithelial cervical lesions in Danish womenBenny Kirschner, Doris Schledermann, Katsiaryna Holl, et al.
Acta Obstetricia Et Gynecologica Scandinavica|June 15, 2013
HPV genotypes in invasive cervical cancer in Danish womenBenny Kirschner, Jette Junge, Katsiaryna Holl, et al.
Gynecologic Oncology|March 11, 2014
Prevalence of Human Papillomavirus in endometrial cancer: a systematic review and meta-analysisTina Bech Olesen, Malene Frøsig Svahn, Mette Tuxen Faber, et al.
Gynecologic Oncology|January 22, 2017
Parity, infertility, oral contraceptives, and hormone replacement therapy and the risk of ovarian serous borderline tumors: A nationwide case-control studyEmma L Kaderly Rasmussen, Charlotte Gerd Hannibal, Christian Dehlendorff, et al.
The American Journal of Surgical Pathology|September 5, 2014
BRAF mutation is associated with a specific cell type with features suggestive of senescence in ovarian serous borderline (atypical proliferative) tumorsFelix Zeppernick, Laura Ardighieri, Charlotte G Hannibal, et al.
The Journal of Pathology|December 6, 2013
Mutational analysis of BRAF and KRAS in ovarian serous borderline (atypical proliferative) tumours and associated peritoneal implantsLaura Ardighieri, Felix Zeppernick, Charlotte G Hannibal, et al.
Gynecologic Oncology|June 14, 2014
A nationwide study of serous "borderline" ovarian tumors in Denmark 1978-2002: centralized pathology review and overall survival compared with the general populationCharlotte Gerd Hannibal, Russell Vang, Jette Junge, et al.
BMC Infectious Diseases|June 3, 2014
Adherence to the cervical cancer screening program in women living with HIV in Denmark: comparison with the general populationKristina Thorsteinsson, Steen Ladelund, Søren Jensen-Fangel, et al.
Sexually Transmitted Diseases|February 17, 2012
Human papillomavirus prevalence and type distribution in 3603 HIV-positive and HIV-negative women in the general population of Tanzania: the PROTECT studyMyassa Dartell, Vibeke Rasch, Crispin Kahesa, et al.
Pageof 4